TREA

87699902 - Z

Follow

Information

  • Trademark
  • 87699902
  • Serial Number
    87699902
  • Filing Date
    November 28, 2017
    8 years ago
  • Transaction Date
    May 08, 2019
    6 years ago
  • Status Date
    May 08, 2019
    6 years ago
  • Location Date
    May 08, 2019
    6 years ago
  • Status Code
    602
  • Current Location
    TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    CALLAGHAN, BRIAN P
  • Attorney Docket Number
    76724
    Attorney Name
    John Pickerill
    Law Office Assigned Location Code
    L80
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
Z
Case File Statements
  • CC0000: The color(s) The colors teal, light blue, light green and white are claimed as a feature of the mark is/are claimed as a feature of the mark.
  • DM0000: The mark consists of the letter "Z" in a stylized font centered within a circle where the color teal transitions first to light blue, then back to teal, and finally to the color light green from left to right.
  • GS0051: Medicines for intestinal disorders; pharmaceutical preparations for use in gastroenterology, for the prevention and treatment of diarrhea, antibiotic-associated diarrhea, travellers' diarrhea, for colon and digestive system health and regulation, for improving energy levels, and for maintaining and improving mucous levels and the mucosal lining of the intestines and colon; pharmaceutical preparations for use in sanitary preparations for medical purposes, namely, nutraceutical preparations for colon and digestive system health and regulation, for maintenance and improvement of energy levels, and for maintaining and improving mucous levels and the mucosal lining of the intestines and colon; pharmaceutical preparations for stimulating the growth of intestinal flora, restoring energy and metabolism of the colocyte and rescuing of the colonic mucosal trophism; pharmaceutical preparations for the treatment of colon disorders; pharmaceutical preparations for improving epithelial vitality and repair; pharmaceutical preparations for the prevention or treatment of cancer; pharmaceutical preparations for the prevention or treatment of colorectal cancer; pharmaceutical preparations for restoring the metabolic balance; pharmaceutical preparations for improving the trophic conditions of the mucosa; pharmaceutical preparations for regulating human gut homeostasis; pharmaceutical preparations for the treatment of gastro-intestinal disorders; pharmaceutical preparations for the treatment of inflammatory bowel disease, motility and functional disorders of the bowel such as IBS and colorectal tumours; pharmaceutical preparations for the maintenance of colon eubiosis; pharmaceutical preparations for decreasing intestinal inflammation; pharmaceutical preparations for promoting, supporting and maintaining a healthy colon; pharmaceutical preparations for the treatment of colitis, ulcerative colitis, Crohn's disease, radiation colitis, pouchitis, infectious colitis and shigellosis; pharmaceutical preparations for the treatment of polyposis of the colon; pharmaceutical preparations for the treatment of pain; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; pharmaceutical and veterinary preparations in the form of tablets, capsules, sugar-coated pills, granules, powders or suppositories for use in treating gastrointestinal diseases and conditions; Pharmaceutical preparations, namely, anti-flatulars; sanitary preparations for medical purposes; dietetic foods adapted for medical use; dietetic beverages and food adapted for medical use; pharmaceutical preparations for the treatment of the intestinal infections; pharmaceutical preparations used to treat gastro-intestinal diseases and conditions, diagnostic agents, preparations and substances related to the gastro-intestinal field for medical purposes; medical preparation based on butyric acid and inulin that contributes to the restoration of intestinal barrier; lactic ferments for pharmaceutical use; biological preparations for use in the gastrointestinal diseases and conditions; food supplements; dietary supplements; vitamin supplements; nutritional supplements; dietary supplemental drinks; vitamin preparations in the form of food supplements; nutraceutical products for use as dietary supplements; Nutraceutical preparations for therapeutic or medical purposes; Mineral supplements for human use
  • GS0101: Medical apparatus for introducing pharmaceutical preparations, food supplements and nutraceuticals into the human body; Medical apparatus for introducing pharmaceutical preparations, food supplements and nutraceuticals into the colon; Enema apparatus; Enema syringes; Enema apparatus for medical purposes; Medical apparatus for introducing enema preparations into the human body; Injection syringes; Syringes for medical purposes; Surgical devices and instruments; Disposable syringes; Medical device for use in diagnosis and treatment of the gastro-intestinal tract
Case File Event Statements
  • 5/8/2019 - 6 years ago
    18 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2
  • 5/8/2019 - 6 years ago
    17 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 10/10/2018 - 7 years ago
    16 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 10/10/2018 - 7 years ago
    15 - FINAL REFUSAL E-MAILED Type: GNFR
  • 10/10/2018 - 7 years ago
    14 - FINAL REFUSAL WRITTEN Type: CNFR
  • 9/13/2018 - 7 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/13/2018 - 7 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/13/2018 - 7 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/14/2018 - 7 years ago
    10 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/14/2018 - 7 years ago
    9 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/14/2018 - 7 years ago
    8 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/14/2018 - 7 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/14/2018 - 7 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/14/2018 - 7 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/12/2018 - 7 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/9/2017 - 7 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 12/8/2017 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 12/1/2017 - 7 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP